Veracyte Inc (Symbol: VCYT) has seen its share price rise to $34.02, exceeding the average analyst 12-month target of $32.83. This pivotal moment occurs amid varied analyst outlooks, with target prices ranging from a low of $26.00 to a high of $37.00. The standard deviation among these targets is noted at $4.708.
Currently, analyst ratings for Veracyte show 6 strong buy ratings, 1 buy rating, 2 hold ratings, and 1 strong sell rating, yielding an average rating of 1.83 (where 1 is a strong buy and 5 is a strong sell). This data reveals an encouraging sentiment from analysts as investors reconsider the potential for further increases in share value or the need to secure profits.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
